drugset / Trial / NCT02673164
Stem Cell Therapy in IschEmic Non-treatable Cardiac Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of the SCIENCE study is, in an international multicentre double-blind placebo-controlled study, to investigate efficacy of direct intra-myocardial injection of 100 mio. allogeneic Cardiology Stem Cell Centre\_adipose derived stem cells (CSCC\_ASCs) in patients with reduced left ventricular Ejection Fraction (EF) (≤45%) and heart failure.
Timeline
- Start
- 2017-01
- Primary completion
- 2020-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CSCC_ASC | Cell therapy | 1e+08 cells | Other |